Login / Signup

[Neurodevelopmental proteasomopathies: New disorders caused by proteasome dysfunction].

Silvestre CuinatStéphane BézieauWallid DebSandra MercierVirginie VignardBérénice ToutainBertrand IsidorSébastien KüryFrédéric Ebstein
Published in: Medecine sciences : M/S (2024)
The ubiquitin-proteasome system (UPS) is a conserved degradation pathway in eukaryotes, playing a central role in various cellular processes, including maintaining protein homeostasis, regulating the cell cycle and signaling pathways, as well as orchestrating cell survival and death. Proteins targeted for UPS-mediated degradation undergo ubiquitin chain modification before being degraded by 26S proteasomes. Recently, a correlation has emerged between pathogenic proteasome variants and the onset of neurodevelopmental disorders. Termed "neurodevelopmental proteasomopathies", these syndromes are rare and characterized by delayed psychomotor development, behavioral disorders, facial dysmorphia, and multisystemic anomalies. In this review, we examine current knowledge on proteasomal dysfunctions and assess their relevance in the search for biomarkers for the diagnosis and potential treatment of these syndromic proteasomopathies.
Keyphrases
  • cell cycle
  • cell proliferation
  • small molecule
  • healthcare
  • congenital heart disease
  • transcription factor
  • oxidative stress
  • copy number
  • drug delivery
  • genome wide
  • combination therapy
  • smoking cessation